首页> 外文OA文献 >Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in Costa Rican adults
【2h】

Genetic variation in stearoyl-CoA desaturase 1 is associated with metabolic syndrome prevalence in Costa Rican adults

机译:硬脂酰辅酶a去饱和酶1的遗传变异与哥斯达黎加成年人的代谢综合征患病率相关

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Stearoyl-CoA desaturase 1 (SCD1) activity, a key regulator of lipid metabolism, may be associated with the development of metabolic syndrome (MetS). We examined the association of genetic variation in the SCD1 gene with the occurrence of MetS and its five components in a population of Costa Rican adults (n = 2152; mean age, 58 y; range, 18-86 y). Associations of tag single nucleotide polymorphisms (tagSNP) of the SCD1 gene with prevalence of MetS and its five components were analyzed by use of log-Poisson models with robust variance estimates and linear regression models, respectively. The likelihood ratio was used to test potential gene-fatty acid interactive effects with adipose tissue alpha-linolenic acid. One tagSNP (rs1502593) was significantly associated with an increased prevalence of MetS in the total study sample. Compared with the common homozygous CC genotype, the CT and TT genotypes for rs1502593 were associated with higher prevalence ratios (PR) of MetS for CT vs. CC: [PR = 1.22 (95% CI = 1.03, 1.44)] and for TT vs. CC [PR = 1.24 (95% CI = 1.01, 1.52)]. Among women, we observed borderline positive associations between systolic blood pressure and fasting blood sugar levels and rs1502593 (P = 0.05 and 0.06). Compared to the common haplotype (frequency \u3e/= 5%) with no minor alleles of SCD1 tagSNP, the other two observed common haplotypes carrying the rs1502593 minor allele were significantly associated with elevated prevalence of MetS. No gene-fatty acid interactive effects were observed. Our results suggest that genetic variation in the SCD1 gene may play a role in the development of MetS.
机译:硬脂酰辅酶A去饱和酶1(SCD1)活性,脂质代谢的关键调节剂,可能与代谢综合征(MetS)的发展有关。我们研究了哥斯达黎加成年人群(n = 2152;平均年龄:58岁;范围:18-86岁)中SCD1基因遗传变异与MetS及其五种成分的发生之间的关系。分别使用对数泊松模型,鲁棒方差估计和线性回归模型,分析了SCD1基因的标签单核苷酸多态性(tagSNP)与MetS及其五个成分的患病率之间的关系。似然比用于测试与脂肪组织α-亚麻酸的潜在基因-脂肪酸相互作用。在整个研究样本中,一种tagSNP(rs1502593)与MetS患病率增加显着相关。与普通纯合CC基因型相比,rs1502593的CT和TT基因型与CT vs. CC的MetS患病率较高(PR):[PR = 1.22(95%CI = 1.03,1.44)]和TT vs CC [PR = 1.24(95%CI = 1.01,1.52)]。在女性中,我们观察到收缩压与空腹血糖水平和rs1502593之间的临界正相关(P = 0.05和0.06)。与没有SCD1 tagSNP的次要等位基因的普通单倍型(频率\ u3e / = 5%)相比,其他两个观察到的带有rs1502593次要等位基因的普通单倍型与MetS的患病率显着相关。没有观察到基因-脂肪酸相互作用的影响。我们的结果表明,SCD1基因的遗传变异可能在MetS的发展中起作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号